UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey

Journal of antimicrobial chemotherapy, 2020-11, Vol.75 (11), p.3386-3390

2020

Volltextzugriff (PDF)

IRI the International Standard for the Ionosphere

Advances in radio science, 2018-09, Vol.16, p.1-11

Bilitza, Dieter

2018

Volltextzugriff (PDF)

The IRI Marketing Data Set

Marketing science (Providence, R.I.), 2008-07, Vol.27 (4), p.745-748

2008

Volltextzugriff (PDF)

Recent Approaches to Targeting Canonical NF κ B Signaling in the Early Inflammatory Response to Renal IRI

Journal of the American Society of Nephrology, 2021-09, Vol.32 (9), p.2117-2124

2021

Volltextzugriff (PDF)

Use of random forests regression for predicting IRI of asphalt pavements

Construction & building materials, 2018-11, Vol.189, p.890-897

2018

Volltextzugriff (PDF)

2022 IRI CTO Forum Summary

Research technology management, 2023-01, Vol.66 (1), p.26-29

2023

Volltextzugriff (PDF)

Suppressing succinate accumulation during ischemia protects the kidney from IRI

Kidney international, 2023-10, Vol.104 (4), p.646-649

2023

Volltextzugriff (PDF)

Performance of IRI 2016 model in predicting total electron content (TEC) compared with GPS-TEC over East Africa during 2019-2021

Scientific reports, 2024-05, Vol.14 (1), p.10010-10010, Article 10010

Sulungu, Emmanuel D

2024

Volltextzugriff (PDF)

Performance evaluation of IRI, IRI Plas and SAMI2 during the consecutive prolonged solar minimum of cycles 23 and 24 around 100°E

Advances in space research, 2023-09, Vol.72 (5), p.1665-1687

2023

Volltextzugriff (PDF)

Obesity Aggravates Ischemia-Reperfusion Injury (IRI)-Induced AKI in Mice: SA-PO072

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.621-621

2022

Volltextzugriff (PDF)

The IRI Medal

Research technology management, 2021-03, Vol.64 (2), p.18-19

2021

Volltextzugriff (PDF)

Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study)

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.655-655

2024

Volltextzugriff (PDF)

Measurement of pavement unevenness and evaluation through the IRI parameter – An overview

Measurement : journal of the International Measurement Confederation, 2023-01, Vol.206, p.112284, Article 112284

2023

Volltextzugriff (PDF)

Unpublished Ration texts from Iri-Sagrig (iri-sag-rig7 ki )

Ātār al-rāfidayn (Online), 2023-06, Vol.8 (2), p.3-25

2023

Volltextzugriff (PDF)

Effects of Sevoflurane on Apoptosis of Myocardial Cells in IRI Rats

BioMed research international, 2021, Vol.2021 (1), p.3347949-3347949

2021

Volltextzugriff (PDF)

Randomized phase II study of nalicap (nal-IRI/capecitabine) compared to NAPOLI (nal-IRI/5-FU/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS621-TPS621

2022

Volltextzugriff (PDF)

Development and validation of the Illness Representation Interview (IRI)

European psychiatry, 2024-08, Vol.67 (S1), p.S97-S98

2024

Volltextzugriff (PDF)

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma: NEO-Nal-IRI study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4190-TPS4190

2023

Volltextzugriff (PDF)

Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16116-e16116

2020

Volltextzugriff (PDF)

Regorafenib (REG) combined with irinotecan (IRI) versus IRI alone as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas (mGA): A randomized phase II trial (PRODIGE 58 – UCGI 35 – REGIRI)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.387-387

2023

Volltextzugriff (PDF)

1838P Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

Annals of oncology, 2020-09, Vol.31, p.S1056-S1056

2020

Volltextzugriff (PDF)

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS778-TPS778

2023

Volltextzugriff (PDF)

Questions and Answers From IRI's Members: What are IRI members talking about? These questions were recently posed on IRI's Community Forum

Research technology management, 2016-07, Vol.59 (4), p.61-65

2016

Volltextzugriff (PDF)

Predicting IRI Using Machine Learning Techniques

International journal of pavement research & technology, 2023-01, Vol.16 (1), p.128-137

2023

Volltextzugriff (PDF)

Micro-RNA-21 rs1292037 A>G polymorphism can predict hepatocellular carcinoma prognosis (HCC), and plays a key role in cell proliferation and ischemia-reperfusion injury (IRI) in HCC cell model of IRI

Saudi medical journal, 2020-04, Vol.41 (4), p.383-392

2020

Volltextzugriff (PDF)

1 – 25 von 210.057

Suche als RSS-Feed

Aktive Filter

ThemaInternal Medicine

ThemaPhysical Sciences

ThemaSocial Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60.545)
Mit Volltextzugriff
(115.942)

Publikationsform

Artikel
(107.780)
Dissertationen
(51.701)
magazinearticle
(18.127)
Reviews
(8.796)
Buchkapitel
(7.682)
Newsletter-Artikel
(5.870)
Zeitungsartikel
(4.467)
Tagungsberichte
(4.229)
Texte
(725)
Bücher
(422)
Berichte
(138)
Referenzeintrag
(95)
Webseiten
(23)
Datensätze
(1)
Bilder
(1)

10 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(170.048)
Türkisch
(25.172)
Portugiesisch
(6.454)
Deutsch
(2.861)
Spanisch
(2.314)
Japanisch
(2.130)
Französisch
(1.568)
Italienisch
(783)
Latein
(526)
Niederländisch
(457)
Russisch
(444)
Chinesisch
(313)
Rumänisch
(294)
Croatian
(187)
Slowenisch
(141)
Ungarisch
(128)
Litauisch
(97)
Hindi
(92)
Koreanisch
(73)
Polnisch
(63)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(32.174)
Life Sciences & Biomedicine
(21.159)
Humans
(10.825)
Technology
(9.537)
Animals
(7.956)
Male
(7.661)
Engineering
(6.368)
Computer Science
(6.273)
Female
(5.482)
Marketing
(5.385)
Adult
(3.495)
Consumers
(3.482)
Middle Eastern Studies
(3.330)
Biological And Medical Sciences
(3.234)
Medicine
(3.160)
Education
(3.155)
Ischemia
(3.082)
Middle Aged
(3.055)
Surgery
(2.994)
Mathematics
(2.738)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

ProQuest Dissertations & Theses A&I
(51.687)
EZB Electronic Journals Library
(33.666)
Nexis Uni
(32.015)
IngentaConnect
(25.212)
Access via Business Source (EBSCOhost)
(18.052)
MEDLINE
(16.703)
Publisher or Other Site
(14.769)
IngentaConnect Journals
(14.443)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(11.639)
JSTOR All Journals
(10.044)
SpringerLink
(7.664)
Ebook Central Perpetual and DDA
(6.373)
Wiley-Blackwell Journals
(6.353)
eBooks on EBSCOhost
(6.195)
Access via ScienceDirect (Elsevier)
(5.507)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4.670)
Taylor & Francis Online
(4.639)
AUTh Library subscriptions: Taylor & Francis Journals
(4.473)
Access via Taylor & Francis
(4.457)
Wiley Online Library
(4.346)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Women’s Wear
(3.517)
The Spectator
(2.987)
The European Magazine, And London Review
(2.850)
Women’s Wear Daily
(2.353)
The Scots Magazine, 1739-1803
(2.322)
The Athenaeum
(1.946)
Pr Newswire
(1.897)
Mmr
(1.751)
Business Wire
(1.571)
Chain Drug Review
(1.567)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey

IRI the International Standard for the Ionosphere

The IRI Marketing Data Set

Recent Approaches to Targeting Canonical NF κ B Signaling in the Early Inflammatory Response to Renal IRI

Use of random forests regression for predicting IRI of asphalt pavements

2022 IRI CTO Forum Summary

Suppressing succinate accumulation during ischemia protects the kidney from IRI

Performance of IRI 2016 model in predicting total electron content (TEC) compared with GPS-TEC over East Africa during 2019-2021

Performance evaluation of IRI, IRI Plas and SAMI2 during the consecutive prolonged solar minimum of cycles 23 and 24 around 100°E

Obesity Aggravates Ischemia-Reperfusion Injury (IRI)-Induced AKI in Mice: SA-PO072

The IRI Medal

Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study)

Measurement of pavement unevenness and evaluation through the IRI parameter – An overview

Unpublished Ration texts from Iri-Sagrig (iri-sag-rig7 ki )

Effects of Sevoflurane on Apoptosis of Myocardial Cells in IRI Rats

Randomized phase II study of nalicap (nal-IRI/capecitabine) compared to NAPOLI (nal-IRI/5-FU/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress

Development and validation of the Illness Representation Interview (IRI)

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma: NEO-Nal-IRI study

Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

Regorafenib (REG) combined with irinotecan (IRI) versus IRI alone as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas (mGA): A randomized phase II trial (PRODIGE 58 – UCGI 35 – REGIRI)

1838P Do irinotecan (IRI) dose reductions driven by UGT1A128 genotyping prevent IRI-related severe neutropenia? A real-world study

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study)

Questions and Answers From IRI's Members: What are IRI members talking about? These questions were recently posed on IRI's Community Forum

Predicting IRI Using Machine Learning Techniques

Micro-RNA-21 rs1292037 A>G polymorphism can predict hepatocellular carcinoma prognosis (HCC), and plays a key role in cell proliferation and ischemia-reperfusion injury (IRI) in HCC cell model of IRI

Aktive Filter

Suchergebnisse filtern